NASDAQ:URGN | EBITDA | UroGen Pharma Ltd.

Complete source-backed ebitda history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30$211,000.00
2026-03-31-$20.19M
2025-12-31-$19.04M
2025-09-30-$27.29M
2025-06-30-$41.35M
2025-03-31-$36.84M
2024-12-31-$27.59M
2024-09-30-$17.45M
2024-06-30-$25.74M
2024-03-31-$25.62M
2023-12-31-$14.42M
2023-09-30-$13.3M
2023-06-30-$15.18M
2023-03-31-$21.83M
2022-12-31-$20.05M
2022-09-30-$17.89M
2022-06-30-$18.52M
2022-03-31-$21.74M
2021-12-31-$19.7M
2021-09-30-$23.24M
2021-06-30-$22.62M
2021-03-31-$25.92M
2020-12-31-$27.13M
2020-09-30-$29.02M
2020-06-30-$31.7M
2020-03-31-$38.46M
2019-12-31-$39.74M
2019-09-30-$23.35M
2019-06-30-$23.65M
2019-03-31-$22.33M
2018-12-31-$23.82M
2018-09-30-$20.99M
2018-06-30-$18.39M
2018-03-31-$13.44M

Annual EBITDA

DateEBITDA
2025-12-31-$124.56M
2024-12-31-$96.45M
2023-12-31-$64.73M
2022-12-31-$78.12M
2021-12-31-$91.46M
2020-12-31-$126.32M
2019-12-31-$109.18M
2018-12-31-$76.78M
2017-12-31-$19.75M
2016-12-31$998,000.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.